Document Detail


Influence of breast cancer histology on the relationship between ultrasound and pathology tumor size measurements.
MedLine Citation:
PMID:  15105809     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Establishing an accurate primary invasive breast cancer size is crucial for patient management. Although ultrasonographic measurement is reported to correlate reliably with the gold standard pathology measurement, few authors have examined the influence of histologic subtype on ultrasound measurement. The common subtypes of invasive breast carcinoma, ductal and lobular, have different growth patterns, which may influence the ability of ultrasound to predict pathologic size. For this analysis, ultrasound and pathology reports were retrospectively reviewed for 204 women with 210 invasive breast cancers, including 129 ductal, 41 lobular, and 40 mixed pattern ductal and lobular carcinomas. For each tumor, the largest pathology and ultrasound dimensions were compared using Pearson's correlations, linear regression, paired t-tests and Wilcoxon signed ranks tests, stratified by histologic subtype. The Hodges-Lehmann approach was used to obtain 95% confidence intervals (CI) for median difference of the sizes. Ultrasonography consistently underestimated pathologic tumor size; the overall median difference was 3.5 mm (CI: 2.5-4.0 mm) and for subtypes: 2.5 mm (CI: 1.5-3.5 mm) for ductal pattern; 3.0 mm (CI: 1.5-4.5 mm) for mixed pattern; and in contrast, 7.5 mm (CI: 5.0-13.5 mm) for lobular pattern tumors. Significant correlations of similar magnitude, were observed between size measurements for ductal, lobular, and mixed subtypes (r=0.816, 0.811 and 0.672, respectively; all P<0.001); however, linear regression models differed between subtypes. Although practical and widely available, ultrasonography tends to underestimate pathologic tumor size. The size difference may be large for lobular carcinomas, potentially influencing stage; differences are less pronounced for ductal and mixed subtypes. Pathologic tumor size can be estimated from the ultrasonographic measurement, particularly if the histologic tumor subtype is known. The results of this study underscore the continued benefit of pretreatment tumor histology.
Authors:
Bobbi Pritt; Takamaru Ashikaga; Robert G Oppenheimer; Donald L Weaver
Related Documents :
8466849 - Tumor cell proliferation and motility estimates are prognostic factors in malignant mel...
25482099 - The orthotopic xenotransplant of human glioblastoma successfully recapitulates glioblas...
17357309 - Tumor front grading in prediction of survival and lymph node metastases in patients wit...
19621009 - On the use of change in tumor size to predict survival in clinical oncology studies: to...
15805689 - Feasibility of breast conservation surgery in locally advanced breast cancer downstaged...
7617069 - Cathepsin b in predicting the extent of the cervix carcinoma.
2295809 - Idiotypic variation in a human b lymphoma cell line.
15933739 - The human papillomavirus 16 e6 protein can either protect or further sensitize cells to...
8315499 - Tumor targeting in vivo and metabolic fate of 5-[iodine-125]iodo-2'-deoxyuridine follow...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc     Volume:  17     ISSN:  0893-3952     ISO Abbreviation:  Mod. Pathol.     Publication Date:  2004 Aug 
Date Detail:
Created Date:  2004-07-20     Completed Date:  2005-01-05     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  8806605     Medline TA:  Mod Pathol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  905-10     Citation Subset:  IM    
Affiliation:
Department of Pathology, University of Vermont College of Medicine, Burlington, VT 05405-0068, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Breast Neoplasms / pathology*,  ultrasonography*
Carcinoma, Ductal, Breast / pathology,  ultrasonography
Carcinoma, Intraductal, Noninfiltrating / pathology,  ultrasonography
Carcinoma, Lobular / pathology,  ultrasonography
Female
Humans
Linear Models
Pathology, Clinical / methods
Reproducibility of Results
Grant Support
ID/Acronym/Agency:
P30-CA22435/CA/NCI NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Double immunolabeling of central nervous system atypical teratoid/rhabdoid tumors.
Next Document:  Immunohistochemical detection of BCL-3 in lymphoid neoplasms: a survey of 353 cases.